The RECORD Asia-Pacific Atrial Fibrillation Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2674 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-04-30

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF) over one year in patients attending clinical or specialized practices.

The Secondary objectives are:

* To describe key demographics and treatment features in AF patients visiting cardiologists in various countries in Asia-Pacific.
* To establish correlation between control of AF and clinical outcomes.
* To establish correlation between treatment strategies and AF control.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Atrial Fibrillation General Registry

NCT02518984

Atrial Fibrillation

COMPLETED

Chinese Atrial Fibrillation Registry

NCT06987825

Atrial Fibrillation (AF)

RECRUITING

Atrial Fibrillation Ablation Registry

NCT04055961

Atrial Fibrillation

UNKNOWN

Clinical Survey on the Stroke Prevention in Atrial Fibrillation in Asia

NCT04807049

Atrial Fibrillation

COMPLETED

Natural History of COVID-19-Related Atrial Fibrillation

NCT04830774

COVID-19 Atrial Fibrillation New Onset

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient presenting with either:

* History of atrial fibrillation diagnosed \< 1 year by standard Electro-Cardiogram (ECG) or by ECG-Holter monitoring (treated or not or whatever rhythm at inclusion).
* New atrial fibrillation diagnosed by standard ECG or by ECG-Holter monitoring at inclusion visit.
* Patient eligible for a pharmacological treatment of AF (by rhythm or rate control agent).

Exclusion Criteria

* AF due to transient cause (thyrotoxicosis, alcohol intoxication, acute phase of myocardial infarction, pericarditis, myocarditis, electrocution, pulmonary embolism or other pulmonary disease, hydroelectrolytic disorder, metabolic disorder, etc.).
* Post cardiac surgery AF (≤3 months).
* Mentally disabled patients unable to understand or sign the written informed consent.
* Patients unable to comply with follow-up visits.
* Patients with pacemaker, Implantable Cardioverter Defibrillator (ICD).
* Patients scheduled for pulmonary vein ablation, AV node/His bundle ablation, or pacemaker implantation.
* Patient included in any clinical trial in the previous 3 months.
* Pregnant or breastfeeding women.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No